Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1.

Liu, Jie; Guo, Zhen-Ni; Yan, Xiu-Li; Yang, Yi; Huang, Shuo

Liu, Jie; Guo, Zhen-Ni; Yan, Xiu-Li; Yang, Yi; Huang, Shuo.

Afiliación

Liu J; Department of Neurology, Stroke Center & Clinical Trial and Research Center for Stroke, The First Hospital of Jilin University, Changchun, China.
Guo ZN; China National Comprehensive Stroke Center, Changchun, China.
Yan XL; Jilin Provincial Key Laboratory of Cerebrovascular Disease, Changchun, China.
Yang Y; Department of Neurology, Stroke Center & Clinical Trial and Research Center for Stroke, The First Hospital of Jilin University, Changchun, China.
Huang S; China National Comprehensive Stroke Center, Changchun, China.

Front Aging Neurosci ; 13: 755392, 2021.

Article en En | MEDLINE | ID: mdl-34867280

Palabras clave

central nervous system; mechanism; myotonic dystrophy type 1; pathology; treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Etiology_studies Idioma: En Revista: Front Aging Neurosci Año: 2021 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google